Literature DB >> 6327675

Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase.

S N Moreno, R P Mason, R Docampo.   

Abstract

Nifurtimox and nitrofurantoin are reduced by intact rat liver mitochondria to nitro anion radicals whose autoxidation generates superoxide anion as detected by direct electron spin resonance spectroscopy and by spin-trapping experiments, respectively. Although nitroreduction occurred in the presence of respiratory substrates such as beta-hydroxybutyrate, malate-glutamate, succinate, or endogenous substrates, nitro anion radical formation activity was much greater on addition of exogenous reduced pyridine nucleotides. NAD(P)H generated from endogenous mitochondrial NAD(P)+ by intramitochondrial reactions could not be used for the NAD(P)H nitroreductase reactions unless the mitochondria were solubilized by detergent. In addition, NAD(P)H nitroreductase activity was detected in the crude mitochondrial outer membrane fraction, with a higher activity than in mitoplasts and intact mitochondria. These results provide direct evidence of a nitrofuran reductase activity associated with the mitochondrial outer membrane that is far more important than that of respiratory chain enzymes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327675

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole.

Authors:  S Radhika Prathalingham; Shane R Wilkinson; David Horn; John M Kelly
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

2.  Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis.

Authors:  Federica Giordani; Annamaria Buschini; Alessandro Baliani; Marcel Kaiser; Reto Brun; Michael P Barrett; Claudia Pellacani; Paola Poli; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

3.  Trypanocidal activity of aziridinyl nitrobenzamide prodrugs.

Authors:  Chris Bot; Belinda S Hall; Noosheen Bashir; Martin C Taylor; Nuala A Helsby; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

4.  Nitroreductase activity of NADH dehydrogenase of the respiratory redox chain.

Authors:  G E Smyth; B A Orsi
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

5.  Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract.

Authors:  F Rafii; E B Hansen
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.

Authors:  Belinda S Hall; Xinghua Wu; Longqin Hu; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

7.  Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.

Authors:  K H Muhvich; M K Park; R A Myers; L Marzella
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Trypanocidal activity of melamine-based nitroheterocycles.

Authors:  Mhairi L Stewart; Gorka Jimenez Bueno; Alessandro Baliani; Burkhard Klenke; Reto Brun; Janice M Brock; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo.

Authors:  Giselle L Saulnier Sholler; Laurent Brard; Jennifer A Straub; Lee Dorf; Sharon Illeyne; Karen Koto; Satyan Kalkunte; Marcus Bosenberg; Taka Ashikaga; Rae Nishi
Journal:  J Pediatr Hematol Oncol       Date:  2009-03       Impact factor: 1.289

10.  A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.

Authors:  Shane R Wilkinson; Martin C Taylor; David Horn; John M Kelly; Ian Cheeseman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.